Effects of Cu-doped 45S5 bioactive glass on the lipid peroxidation- associated growth of human osteoblast-like cells in vitro

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 10, 2014, Pages 3556-3561

  Milkovic, Lidija ^a   Hoppe, Alexander ^b   Detsch, Rainer ^b   Boccaccini, Aldo R ^b   Zarkovic, Neven ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

4 hydroxynonenal; bioactive glass; biomaterials; copper; lipid peroxidation

Indexed keywords

BIOACTIVE GLASS; BIOMATERIALS; CELL GROWTH; CELLS; GROWTH KINETICS; LIPIDS; OXIDATIVE STRESS;

4-HYDROXY-NONENAL; BENEFICIAL EFFECTS; CU CONCENTRATIONS; HUMAN OSTEOBLAST-LIKE CELLS; LIPID PEROXIDATION; LOW CONCENTRATIONS; OSTEOCONDUCTIVE PROPERTIES; RESEARCH AND DEVELOPMENT;

COPPER;

4 HYDROXYNONENAL; BIOACTIVE GLASS; BIOMATERIAL; COPPER; UNCLASSIFIED DRUG; 4',6 DIAMIDINO 2 PHENYLINDOLE; 4-HYDROXY-2-NONENAL; ALDEHYDE; BIOACTIVE GLASS 45S5; CERAMICS; GLASS; INDOLE DERIVATIVE;

ANALYTIC METHOD; ARTICLE; CELL CULTURE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; ENERGY DISPERSIVE X RAY ANALYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; LIPID PEROXIDATION; OSTEOBLAST; SCANNING ELECTRON MICROSCOPY; CELL PROLIFERATION; CELL SURVIVAL; CERAMICS; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHARMACOLOGY; SPECTROMETRY; TUMOR CELL LINE; ULTRASTRUCTURE;

ALDEHYDES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CERAMICS; COPPER; GLASS; HUMANS; IMMUNOBLOTTING; INDOLES; LIPID PEROXIDATION; OSTEOBLASTS; SPECTROMETRY, X-RAY EMISSION;

EID: 84906786561     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35032     Document Type: Article

References (35)

1. Hench LL, Thompson I,. Twenty-first century challenges for biomaterials. J Roy Soc Interface 2010; 7: 379-391.
2. Hench LL, Splinter RJ, Allen WC, Greenlee TK,. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res 1971; 5: 117-141.
3. Hum J, Boccaccini AR,. Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: A review. J Mater Sci-Mater Med 2012; 23: 2317-2333.
4. Hoppe A, Güldal NS, Boccaccini AR,. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 2011; 32: 2757-2774.
5. Hoppe A, Mouriño V, Boccaccini AR,. Therapeutic inorganic ions in bioactive glasses to enhance bone formation and beyond. Biomater Sci 2013; 1: 254.
6. Wildburger R, Zarkovic̈ N, Egger G, Petek W, Meinitzer A, Borovic̈ S, Zarkovic̈ K, Li L, Stipancic̈ I, Trbojevic̈-Cepe M,. Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro. Eur J Clin Chem Clin Biochem 1995; 33: 693-698.
7. Wildburger R, Borovic̈ S, Zarkovic̈ N, Tatzber F,. Post-traumatic dynamic changes in the antibody titer against oxidized low density lipoproteins. Wien Klin Wochenschr 2000; 112: 798-803.
8. Wildburger R, Zarkovic N, Leb G, Borovic S, Zarkovic K, Tatzber F,. Post-traumatic changes in insulin-like growth factor type 1 and growth hormone in patients with bone fractures and traumatic brain injury. Wien Klin Wochenschr 2001; 113: 119-126.
9. Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H,. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct 1993; 11: 279-286.
10. Kreuzer T, Grube R, Wutte A, Zarkovic N, Schaur RJ,. 4-Hydroxynonenal modifies the effects of serum growth factors on the expression of the c-fos proto-oncogene and the proliferation of HeLa carcinoma cells. Free Radical Biol Med 1998; 25: 42-49.
11. Sunjic SB, Cipak A, Rabuzin F, Wildburger R, Zarkovic N,. The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells. BioFactors 2005; 24: 141-148.
12. Leonarduzzi G, Robbesyn F, Poli G,. Signaling kinases modulated by 4-hydroxynonenal. Free Radical Biol Med 2004; 37: 1694-1702.
13. Borovic S, Cipak A, Meinitzer A, Kejla Z, Perovic D, Waeg G, Zarkovic N,. Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells. Redox Rep 2007; 12: 50-54.
14. Mrakovcic L, Wildburger R, Jaganjac M, Cindric M, Cipak A, Borovic-Sunjic S, Waeg G, Milankovic AM, Zarkovic N,. Lipid peroxidation product 4-hydroxynonenal as factor of oxidative homeostasis supporting bone regeneration with bioactive glasses. Acta Biochim Pol 2010; 57: 173-178.
15. Gérard C, Bordeleau L-J, Barralet J, Doillon CJ,. The stimulation of angiogenesis and collagen deposition by copper. Biomaterials 2010; 31: 824-831.
16. Hayashi T, Shishido N, Nakayama K, Nunomura A, Smith MA, Perry G, Nakamura M,. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Radical Biol Med 2007; 43: 1552-1559.
17. Cazacu M, Oniu T, Lungoci C, Mihailov A, Cipak A, Klinger R, Weiss T, Zarkovic N,. The influence of isorel on the advanced colorectal cancer. Cancer Biother Radiopharm 2003; 18: 27-34.
18. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
19. Rudic̈ M, Milkovic̈ L, Zarkovic̈ K, Borovic̈- Šunjic̈ S, Sterkers O, Waeg G, Ferrary E, Bozorg Grayeli A, Zarkovic̈ N,. The effects of angiotensin II and the oxidative stress mediator 4-hydroxynonenal on human osteoblast-like cell growth: Possible relevance to otosclerosis. Free Radical Biol Med 2012; 57C: 22-28.
20. Valko M, Morris H, Cronin MTD,. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12: 1161-1208.
21. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J,. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
22. Lynch SM, Frei B,. Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein. J Lipid Res 1993; 34: 1745-1753.
23. Gaetke L,. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003; 189: 147-163.
24. Guéraud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L, Jouanin I, Siems W, Uchida K,. Chemistry and biochemistry of lipid peroxidation products. Free Radical Res 2010; 44: 1098-1124.
25. Esterbauer H, Schaur RJ, Zollner H,. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol Med 1991; 11: 81-128.
26. Borovic Sunjic S, Wildburger R, Mittelbach M, Waeg G, Zarkovic N,. Lipid peroxidation end product as a modulator of cell growth. In:, Hayashi T, editor. Cell Growth Processes: New Research. New York: Nova Science Publishers, Inc.; 2007. p 220-237.
27. Awasthi YC, Yang Y, Tiwari NK, Patrick B, Sharma A, Li J, Awasthi S,. Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases. Free Radical Biol Med 2004; 37: 607-619.
28. Uchida K,. 4-Hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog Lipid Res 2003; 42: 318-343.
29. Zarkovic N, Cipak A, Jaganjac M, Borovic S, Zarkovic K,. Pathophysiological relevance of aldehydic protein modifications. J proteomics 2013; 92: 239-247.
30. Siems W, Grune T,. Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 2003; 24: 167-175.
31. Mattson MP,. Hormesis defined. Ageing Res Rev 2008; 7: 1-7.
32. Kreuzer T, Zarkovic N, Grube R, Schaur RJ,. Inhibition of HeLa cell proliferation by 4-hydroxynonenal is associated with enhanced expression of the c-fos oncogene. Cancer Biother Radiopharm 1997; 12: 131-136.
33. Siow RCM, Ishii T, Mann GE,. Modulation of antioxidant gene expression by 4-hydroxynonenal: Atheroprotective role of the Nrf2/ARE transcription pathway. Redox Rep 2007; 12: 11-15.
34. Parola M, Bellomo G, Robino G, Barrera G, Dianzani MU,. 4-Hydroxynonenal as a biological signal: Molecular basis and pathophysiological implications. Antioxid Redox Signaling 1999; 1: 255-284.
35. Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP,. Cellular stress responses, the hormesis paradigm, and vitagenes: Novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signaling 2010; 13: 1763-1811.